JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
UBS
UBS Group AG
There isn't enough reported data to score UBS yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
UBS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
UBS's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like UBS.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over UBS in the historical PE scenario, which offers more potential upside but is not a forecast.
UBS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $17.70 | -63% |
| Fair | 9.8x | $23.26 | -52% |
| Forward | 11x | $48.44 | — |
| Current | 20x | $48.44 | — |
| Expensive | 21x | $49.06 | +1.3% |
Historical ranges are pointers, not guarantees.
UBS's PE is 20x, but its earnings don't support one, so it isn't a reliable read right now.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
UBS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for UBS, with profitability improving.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
UBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.32 | +82% |
| Q4 2025 | $2.38 | +57% |
| Q2 2025 | $1.91 | +19000% |
| Q1 2025 | $1.53 | -81% |
| Q4 2024 | $1.52 | -81% |
| Q2 2024 | $0.01 | -100% |
| Q1 2024 | $8.18 | +317% |
| Q4 2023 | $7.98 | +255% |
| Q2 2023 | $9.86 | +340% |
UBS has the edge over JPM in the latest year-over-year earnings comparison.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
UBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $24.9B | +3.9% |
| Q2 2025 | $18.3B | -0.2% |
| Q1 2025 | $18.9B | -3.4% |
| Q4 2024 | $24B | +6.3% |
| Q2 2024 | $18.3B | +33% |
| Q1 2024 | $19.6B | +71% |
| Q4 2023 | $22.6B | +39% |
| Q2 2023 | $13.8B | +58% |
UBS has the edge over JPM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 18% | +11 points |
| Q2 2025 | 12% | +1 points |
| Q1 2025 | 11% | +20 points |
| Q4 2024 | 12% | -168 points |
| Q2 2024 | 7.2% | -4.7 points |
| Q1 2024 | 11% | -15 points |
| Q4 2023 | -8.8% | -38 points |
| Q2 2023 | 180% | +153 points |
UBS's operating margin was 18% last quarter, up 11 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
UBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $5B | +$5.1B |
| Q1 2025 | $14.8B | +33% |
| Q2 2024 | -$186M | -100% |
| Q1 2024 | $11.1B | +$36.6B |
| Q2 2023 | $42.3B | +$51.8B |
| Q1 2023 | -$25.5B | -195% |
| Q2 2022 | -$9.5B | -$6.5B |
| Q1 2022 | $26.9B | +$26.9B |
UBS's free cash flow was $30.7B over the past year, down 10% from the year before. Free cash flow isn't a meaningful measure for financial services companies like UBS.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over UBS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
UBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -16.3M shares |
| 1 year | -2.1% | -69M shares |
| 3 years | -9.3% | -337M shares |
| 5 years | -15% | -563M shares |
UBS has 3.3B diluted shares, down 2.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $619.1M |
| Q1 2025 | $1.3B |
| Q2 2024 | $813M |
| Q1 2024 | $969.1M |
| Q2 2023 | $78.1M |
| Q1 2023 | $2.2B |
| Q2 2022 | $1.6B |
| Q1 2022 | $1.9B |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
UBS Net Leverage
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
UBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.9 | Neutral |
| Stochastic | 20.3 | Neutral |
UBS's weekly RSI is 49 (neutral) and its Stochastic is 20 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over UBS on valuation relative to its sector.
UBS PE vs Financial Services Sector
| Metric | UBS | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 13x | 56% above |
| PE % | 83 | 63 | 20 pts above |
UBS is trading at 20x earnings, a 56% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
UBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.9 | 1.1% above |
| 20 week MA | $51.0 | 5% below |
| 50 week MA | $46.9 | 3.4% above |
| 100 week MA | $40.9 | 18% above |
| 200 week MA | $33.8 | 43% above |
UBS's trend is mixed: it's above four of its five weekly moving averages, and 43% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over UBS on returns for 2026, with the stronger performance.
UBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.5 | $14.1 | +13% |
| 2021 | $14.1 | $17.8 | +27% |
| 2022 | $17.8 | $18.6 | +4.5% |
| 2023 | $18.6 | $30.9 | +66% |
| 2024 | $30.9 | $30.7 | -0.7% |
| 2025 | $30.7 | $47.3 | +54% |
| 2026 YTD | $47.3 | $48.4 | +2.5% |
UBS has finished higher in five of the last six years, two of them by more than 50%. It's up 2.5% so far in 2026.